Medicine and Dentistry
Acute Decompensated Heart Failure
18%
Allograft
12%
Anticoagulation
18%
Apoplexy
24%
Blood Pressure
12%
Bloodstream Infection
18%
Cancer Treatment
18%
Cannula
24%
Cardiac Catheterization
30%
Cardiac Magnetic Resonance Imaging
18%
Cardiovascular Disease
27%
Cardiovascular System
22%
Congestive Heart Failure
100%
Device for Heart Failure
18%
Diagnosis
18%
Echocardiography
44%
Ejection Fraction
29%
Event Free Survival
18%
Extracorporeal
18%
Extracorporeal Membrane Oxygenation
18%
Hazard Ratio
13%
Heart Failure with Preserved Ejection Fraction
18%
Heart Graft
36%
Heart Left Ventricle Ejection Fraction
20%
Heart Transplantation
49%
Hypertension
12%
Hypogammaglobulinemia
18%
Immune Checkpoint Inhibitor
18%
Immunoglobulin
18%
Immunoglobulin G
18%
Infection
22%
Intra-Aortic Balloon Pump
18%
Intravascular Hemolysis
18%
Left Ventricular Assist Device
40%
Lung Cancer
18%
Myocardial Disease
21%
Oxygen Consumption
24%
Patient Referral
20%
Prevalence
14%
Primary Health Care
18%
Prosthetic Valve Thrombosis
18%
Pulmonary Artery Occlusion Pressure
22%
Pulmonary Hypertension
18%
Retrospective Study
12%
Right Ventricular Function
18%
Systolic Blood Pressure
24%
Systolic Dysfunction
18%
Tissue Plasminogen Activator
18%
Transplantation
22%
Ventricular Assist Device
27%
Keyphrases
Acute Myocardial Infarction
6%
Atrial Shunt Device
18%
Bloodstream Infection
18%
Cannula
6%
Cardiac Index
18%
Cardiac Transplantation
18%
Cardiogenic Shock
6%
Cardiomyopathy
6%
Clinical Diagnostics
6%
Clinical Presentation
6%
Diagnostic Approach
6%
Diagnostic Challenge
6%
Diagnostic Evaluation
6%
Diastolic Dysfunction
6%
Etiology
6%
Fraction Comparison
18%
Heart Transplantation
18%
Heterogeneous Groups
6%
Impella
18%
Impella Device
6%
Intra-aortic Balloon Pump
18%
Left Atrium
6%
Left Ventricle
6%
Mechanical Circulatory Support Device
6%
Mildly Reduced Ejection Fraction
18%
Myocardial Stiffness
6%
Non-invasive Prediction
18%
Oxygen Consumption
24%
Presentation Evaluation
6%
Primary Healthcare Centers
9%
Prolonged Use
18%
R219K
5%
Restrictive Cardiomyopathy
18%
Right Ventricular-pulmonary Arterial Coupling
18%
RV Systolic Dysfunction
18%
Serious Complications
6%
Shunt Device
7%
Single-center Study
18%
Suction
18%
Temporary Mechanical Circulatory Support
6%
Treatment Strategy
6%
Uncommon Causes
6%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
36%
Ventricular Assist Device
19%
Ventricular Relaxation
6%
VO2peak
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
18%
Cardiovascular Disease
27%
Cardiovascular Risk
6%
Congestive Heart Failure
37%
Cross-Sectional Study
6%
Diastolic Dysfunction
6%
Diseases
6%
Hemoglobin A1c
18%
Hospital Mortality
6%
Hypercholesterolemia
12%
Hypertension
12%
Immune Checkpoint Inhibitor
18%
Immunoglobulin
18%
Immunoglobulin Deficiency
18%
Immunoglobulin G
18%
Infection
18%
Lung Cancer
18%
Malignant Neoplasm
19%
Myocardial Disease
24%
Nonischemic Cardiomyopathy
5%
Pharmacotherapy
6%
Population Study
6%
Prevalence
12%
Prosthetic Valve Thrombosis
18%
Restrictive Cardiomyopathy
18%
Retrospective Study
22%
Systolic Hypertension
6%